Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphoma, T-Cell, Peripheral
×
belinostat
×
Clear all
Filters
3
NCT00865969
2021-10-29
PTCL
Spectrum Pharmaceuticals, Inc
Phase 2
Completed
129 enrolled
12 charts
NCT00274651
2015-07-28
PXD101-CLN-6
Valerio Therapeutics
Phase 2
Terminated
53 enrolled
12 charts